{"id":"https://openalex.org/W1978143294","doi":"https://doi.org/10.1021/jm070861j","title":"Structure\u2212Activity and Protraction Relationship of Long-Acting Glucagon-like Peptide-1 Derivatives: Importance of Fatty Acid Length, Polarity, and Bulkiness","display_name":"Structure\u2212Activity and Protraction Relationship of Long-Acting Glucagon-like Peptide-1 Derivatives: Importance of Fatty Acid Length, Polarity, and Bulkiness","publication_year":2007,"publication_date":"2007-11-01","ids":{"openalex":"https://openalex.org/W1978143294","doi":"https://doi.org/10.1021/jm070861j","mag":"1978143294","pmid":"https://pubmed.ncbi.nlm.nih.gov/17975905"},"language":"en","primary_location":{"id":"doi:10.1021/jm070861j","doi":"https://doi.org/10.1021/jm070861j","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm070861j","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078869291","display_name":"Kjeld Madsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Kjeld Madsen","raw_affiliation_strings":["Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088627727","display_name":"Lotte Bjerre Knudsen","orcid":"https://orcid.org/0000-0002-2439-7116","observed_orcids":["https://orcid.org/0000-0002-2439-7116"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Lotte Bjerre Knudsen","raw_affiliation_strings":["Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015426834","display_name":"Henrik Agersoe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Henrik Agersoe","raw_affiliation_strings":["Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055713268","display_name":"Per Franklin Nielsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Per Franklin Nielsen","raw_affiliation_strings":["Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110097757","display_name":"Henning Th\u00f8gersen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Henning Th\u00f8gersen","raw_affiliation_strings":["Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Wilken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Michael Wilken","raw_affiliation_strings":["Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103817822","display_name":"Nils Langeland Johansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Nils Langeland Johansen","raw_affiliation_strings":["Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Protein Engineering, Biology and Pharmacology Management, Exploratory ADME, Protein Science, Structure and Biophysical Chemistry, Antibody and Cell Technology, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I189090001"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":6.7403,"has_fulltext":false,"cited_by_count":243,"citation_normalized_percentile":{"value":0.97262621,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"50","issue":"24","first_page":"6126","last_page":"6132"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9729999899864197},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8669999837875366},{"id":"https://openalex.org/keywords/protraction","display_name":"protraction","score":0.6399999856948853},{"id":"https://openalex.org/keywords/spacer-region","display_name":"spacer region","score":0.9079999923706055},{"id":"https://openalex.org/keywords/drug-potency","display_name":"drug potency","score":0.5569999814033508},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.7419999837875366},{"id":"https://openalex.org/keywords/steric-bulkiness","display_name":"steric bulkiness","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.868472695350647},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.7381927371025085},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.6751242280006409},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.5565829277038574},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5053656697273254},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4805229604244232},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4676401615142822},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.43009358644485474},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.40428096055984497},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2593662738800049},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.10721078515052795},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07089066505432129},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000242","descriptor_name":"Cyclic AMP","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005227","descriptor_name":"Fatty Acids","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D005227","descriptor_name":"Fatty Acids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005227","descriptor_name":"Fatty Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005227","descriptor_name":"Fatty Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013552","descriptor_name":"Swine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm070861j","doi":"https://doi.org/10.1021/jm070861j","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm070861j","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:17975905","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17975905","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1576285254","https://openalex.org/W1965385720","https://openalex.org/W1986331352","https://openalex.org/W1991565451","https://openalex.org/W1993287695","https://openalex.org/W2012437459","https://openalex.org/W2013851956","https://openalex.org/W2019002829","https://openalex.org/W2021058979","https://openalex.org/W2033057963","https://openalex.org/W2043121816","https://openalex.org/W2043324706","https://openalex.org/W2056594490","https://openalex.org/W2063715420","https://openalex.org/W2073996229","https://openalex.org/W2078115857","https://openalex.org/W2082032596","https://openalex.org/W2085862152","https://openalex.org/W2093738306","https://openalex.org/W2099223875","https://openalex.org/W2103525547","https://openalex.org/W2143014102","https://openalex.org/W2154627665","https://openalex.org/W2159205789","https://openalex.org/W2162934281","https://openalex.org/W2167984392"],"related_works":["https://openalex.org/W1986331352","https://openalex.org/W2883180577","https://openalex.org/W2797451084","https://openalex.org/W2071778655","https://openalex.org/W3174467564","https://openalex.org/W2059105549","https://openalex.org/W2295351755","https://openalex.org/W2772942375","https://openalex.org/W2151322171","https://openalex.org/W3202452911"],"abstract_inverted_index":{"We":[0],"here":[1],"report":[2],"a":[3,13],"series":[4],"of":[5,63],"derivatives":[6],"describing":[7],"the":[8,35,39,47,64,68],"structure-activity":[9],"relationship":[10],"around":[11],"liraglutide,":[12],"once-daily":[14],"human":[15],"glucagon-like":[16],"peptide-1":[17],"fatty":[18,36,48,51,65],"acid":[19,37,49,52,66],"derivative,":[20],"with":[21],"respect":[22],"to":[23],"potency":[24,58],"as":[25,27],"well":[26],"protraction":[28],"in":[29],"vivo.":[30],"The":[31,61],"spacer":[32],"region":[33],"between":[34],"and":[38,59],"peptide":[40],"is":[41,54,67],"mostly":[42],"important":[43,55,70],"for":[44,56,72],"potency,":[45],"whereas":[46],"or":[50],"mimetic":[53],"both":[57],"protraction.":[60,73],"length":[62],"most":[69],"parameter":[71]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":20},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":22},{"year":2017,"cited_by_count":21},{"year":2016,"cited_by_count":18},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}